Andrzej Wróbel1, Mirosław Łańcut2, Tomasz Rechberger3. 1. Second Department of Gynecology, Medical University of Lublin, Jaczewskiego 8, PL 20-090 Lublin, Poland. Electronic address: wrobelandrzej@yahoo.com. 2. Department of Histology and Embryology with Experimental Cytology Unit, Medical University of Lublin, Radziwiłłowska 11, PL 20-000 Lublin, Poland. 3. Second Department of Gynecology, Medical University of Lublin, Jaczewskiego 8, PL 20-090 Lublin, Poland.
Abstract
INTRODUCTION: A credible animal overactive bladder model used in basic research is an indispensable harbinger of safe and ethical clinical trials on human subjects. Our objective was to develop a new animal model of a hyperactive bladder that will be void of inflammatory urothelium lesions and display significant sensitivity to muscarinic receptor antagonists. METHODS: To examine the influence of 0.75% retinyl acetate solution on cystometric parameters, it was infused into the bladder for 5min. Cystometric studies with physiological saline were performed in conscious unrestrained rats 3days later. To examine the influence of retinyl acetate, acetic acid or cyclophosphamide on morphology of urinary bladders, the bladders were subjected to histopathological examination. RESULTS: We demonstrated that in rats subject to previous 5-minute bladder instillations with retinyl acetate, an increase of basal pressure, threshold pressure, micturition voiding pressure, bladder contraction duration, relaxation time, detrusor overactivity index, nonvoiding contraction frequency and amplitude occurs. On the other hand, a decrease in voided volume, post-void residual, volume threshold, voiding efficiency, intercontraction interval, bladder compliance and volume threshold to elicit nonvoiding contractions was observed. Administration of oxybutynin chloride (0.5mg/kg, i.v.) reversed changes of cystometric parameters evoked by retinyl acetate. Contrary to acetic acid and cyclophosphamide, bladders subjected to retinyl acetate infusion had no signs of bladder inflammation. DISCUSSION: The results obtained indicate that transient infusion of 0.75% retinyl acetate can induce detrusor overactivity, which is often observed in patients with overactive bladder syndrome (OAB). In addition, it was demonstrated that stimulating afferent C-fibres using retinyl acetate did not induce evident histopathological inflammatory lesions in the urinary bladder wall. It appears that in the future this model can prove useful in gaining more knowledge on the pathophysiology of OAB, and contribute to the preparation of new, more effective options of OAB pharmacotherapy.
INTRODUCTION: A credible animal overactive bladder model used in basic research is an indispensable harbinger of safe and ethical clinical trials on human subjects. Our objective was to develop a new animal model of a hyperactive bladder that will be void of inflammatory urothelium lesions and display significant sensitivity to muscarinic receptor antagonists. METHODS: To examine the influence of 0.75% retinyl acetate solution on cystometric parameters, it was infused into the bladder for 5min. Cystometric studies with physiological saline were performed in conscious unrestrained rats 3days later. To examine the influence of retinyl acetate, acetic acid or cyclophosphamide on morphology of urinary bladders, the bladders were subjected to histopathological examination. RESULTS: We demonstrated that in rats subject to previous 5-minute bladder instillations with retinyl acetate, an increase of basal pressure, threshold pressure, micturition voiding pressure, bladder contraction duration, relaxation time, detrusor overactivity index, nonvoiding contraction frequency and amplitude occurs. On the other hand, a decrease in voided volume, post-void residual, volume threshold, voiding efficiency, intercontraction interval, bladder compliance and volume threshold to elicit nonvoiding contractions was observed. Administration of oxybutynin chloride (0.5mg/kg, i.v.) reversed changes of cystometric parameters evoked by retinyl acetate. Contrary to acetic acid and cyclophosphamide, bladders subjected to retinyl acetate infusion had no signs of bladder inflammation. DISCUSSION: The results obtained indicate that transient infusion of 0.75% retinyl acetate can induce detrusor overactivity, which is often observed in patients with overactive bladder syndrome (OAB). In addition, it was demonstrated that stimulating afferent C-fibres using retinyl acetate did not induce evident histopathological inflammatory lesions in the urinary bladder wall. It appears that in the future this model can prove useful in gaining more knowledge on the pathophysiology of OAB, and contribute to the preparation of new, more effective options of OAB pharmacotherapy.
Authors: Marcus J Drake; Anthony Kanai; Dominika A Bijos; Youko Ikeda; Irina Zabbarova; Bahareh Vahabi; Christopher H Fry Journal: BJU Int Date: 2016-08-23 Impact factor: 5.588
Authors: Woo Hyun Kim; Woong Jin Bae; Jung Woo Park; Jin Bong Choi; Su Jin Kim; Hyuk Jin Cho; U Syn Ha; Sung Hoo Hong; Ji Youl Lee; Sung Yeoun Hwang; Sae Woong Kim Journal: World J Mens Health Date: 2016-08-23 Impact factor: 5.400
Authors: Brian M Balog; Abhilasha Tangada; Pooja Sheth; Qi-Xiang Song; Bruna M Couri; Leah L Porras; Gary G Deng; Margot S Damaser Journal: PLoS One Date: 2019-08-28 Impact factor: 3.240
Authors: Andrzej Wróbel; Łukasz Zapała; Tomasz Kluz; Artur Rogowski; Marcin Misiek; Kajetan Juszczak; Jacek Sieńko; Daniela Gold; Klaudia Stangel-Wójcikiewicz; Ewa Poleszak; Piotr Radziszewski Journal: Int J Mol Sci Date: 2021-05-29 Impact factor: 5.923
Authors: Andrzej Wróbel; Anna Serefko; Aleksandra Szopa; Daniela Ulrich; Ewa Poleszak; Tomasz Rechberger Journal: Front Pharmacol Date: 2020-07-08 Impact factor: 5.810
Authors: Basu Chakrabarty; Dominika A Bijos; Bahareh Vahabi; Francesco Clavica; Anthony J Kanai; Anthony E Pickering; Christopher H Fry; Marcus J Drake Journal: Front Physiol Date: 2019-01-10 Impact factor: 4.566